Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1498435

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1498435

Asia Pacific Dementia Treatment Market Size, Share & Trends Analysis Report By Type, By Dementia Drugs Route of Administration, By Dementia Drugs Distribution Channel, By Indication, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 174 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Asia Pacific Dementia Treatment Market would witness market growth of 8.0% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Dementia Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2,139.1 million by 2031. The Japan market is registering a CAGR of 7.3% during (2024 - 2031). Additionally, The India market would capture a CAGR of 8.7% during (2024 - 2031).

The increasing investment in healthcare infrastructure globally is facilitating the growth of the dementia treatment market. In order to accommodate the increasing number of dementia patients, governments and private entities are making investments in the construction as well as modernization of healthcare facilities. This encompasses the establishment of innovative diagnostic tools and therapeutic modalities in specialized memory clinics and dementia care centers. Such investments are crucial in enhancing the early detection and management of dementia, improving patient outcomes and quality of life.

Pharmacological treatments remain a cornerstone of dementia management, with ongoing research focused on developing new and more effective medications. Current treatments primarily aim to manage symptoms and improve cognitive function. Cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, are commonly prescribed to improve cognitive symptoms in mild to moderate Alzheimer's disease. NMDA receptor antagonists, like memantine, treat moderate to severe cases.

In India, the demand for dementia treatment is growing due to the increasing prevalence of dementia and the country's aging population. According to the National Library of Medicine, approximately 8.8 million people in India were living with dementia in 2023, a number expected to increase significantly in the coming decades. The Indian government has been working to improve dementia care through initiatives like the National Programme for Health Care of the Elderly (NPHCE), which includes provisions for dementia care and support. Increased awareness, early diagnosis efforts, and investments in healthcare infrastructure drive the demand for dementia treatments in India. Therefore, the demand for dementia treatments will rise significantly in this region in the coming years.

Based on Type, the market is segmented into Diagnosis (Imaging Techniques, Cognitive Assessment Tools, Genetic Testing, Biomarker Analysis and Others) and Drugs (Cholinesterase Inhibitors, NMDA Receptor Antagonist, MAO Inhibitors, Combination Drug and Others). Based on Dementia Drugs Route of Administration, the market is segmented into Oral, Transdermal Patch, and Injectable. Based on Dementia Drugs Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on Indication, the market is segmented into Alzheimer's Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia (FTD), Parkinson Disease Dementia and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • Eisai Co., Ltd.
  • Eli Lilly And Company
  • F. Hoffmann-La Roche Ltd.
  • Biogen, Inc.
  • AbbVie, Inc.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • GlaxoSmithKline PLC (GSK)
  • Cipla Limited

Asia Pacific Dementia Treatment Market Report Segmentation

By Type

  • Diagnosis
    • Imaging Techniques
    • Cognitive Assessment Tools
    • Genetic Testing
    • Biomarker Analysis
    • Others
  • Drugs
    • Cholinesterase Inhibitors
    • NMDA Receptor Antagonist
    • MAO Inhibitors
    • Combination Drug
    • Others

By Dementia Drugs Route of Administration

  • Oral
  • Transdermal Patch
  • Injectable

By Dementia Drugs Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Indication

  • Alzheimer's Disease Dementia
  • Vascular Dementia
  • Lewy Body Dementia
  • Frontotemporal Dementia (FTD)
  • Parkinson Disease Dementia
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Dementia Treatment Market, by Type
    • 1.4.2 Asia Pacific Dementia Treatment Market, by Dementia Drugs Route of Administration
    • 1.4.3 Asia Pacific Dementia Treatment Market, by Dementia Drugs Distribution Channel
    • 1.4.4 Asia Pacific Dementia Treatment Market, by Indication
    • 1.4.5 Asia Pacific Dementia Treatment Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Dementia Treatment Market by Type

  • 4.1 Asia Pacific Diagnosis Market by Country
  • 4.2 Asia Pacific Dementia Treatment Market by Diagnosis Type
    • 4.2.1 Asia Pacific Imaging Techniques Market by Country
    • 4.2.2 Asia Pacific Cognitive Assessment Tools Market by Country
    • 4.2.3 Asia Pacific Genetic Testing Market by Country
    • 4.2.4 Asia Pacific Biomarker Analysis Market by Country
    • 4.2.5 Asia Pacific Others Market by Country
  • 4.3 Asia Pacific Drugs Market by Country
  • 4.4 Asia Pacific Dementia Treatment Market by Drug Class
    • 4.4.1 Asia Pacific Cholinesterase Inhibitors Market by Country
    • 4.4.2 Asia Pacific NMDA Receptor Antagonist Market by Country
    • 4.4.3 Asia Pacific MAO Inhibitors Market by Country
    • 4.4.4 Asia Pacific Combination Drug Market by Country
    • 4.4.5 Asia Pacific Others Market by Country

Chapter 5. Asia Pacific Dementia Treatment Market by Dementia Drugs Route of Administration

  • 5.1 Asia Pacific Oral Market by Country
  • 5.2 Asia Pacific Transdermal Patch Market by Country
  • 5.3 Asia Pacific Injectable Market by Country

Chapter 6. Asia Pacific Dementia Treatment Market by Dementia Drugs Distribution Channel

  • 6.1 Asia Pacific Hospital Pharmacy Market by Country
  • 6.2 Asia Pacific Retail Pharmacy Market by Country
  • 6.3 Asia Pacific Online Pharmacy Market by Country

Chapter 7. Asia Pacific Dementia Treatment Market by Indication

  • 7.1 Asia Pacific Alzheimer's Disease Dementia Market by Country
  • 7.2 Asia Pacific Vascular Dementia Market by Country
  • 7.3 Asia Pacific Lewy Body Dementia Market by Country
  • 7.4 Asia Pacific Frontotemporal Dementia (FTD) Market by Country
  • 7.5 Asia Pacific Parkinson Disease Dementia Market by Country
  • 7.6 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific Dementia Treatment Market by Country

  • 8.1 China Dementia Treatment Market
    • 8.1.1 China Dementia Treatment Market by Type
      • 8.1.1.1 China Dementia Treatment Market by Diagnosis Type
      • 8.1.1.2 China Dementia Treatment Market by Drug Class
    • 8.1.2 China Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.1.3 China Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.1.4 China Dementia Treatment Market by Indication
  • 8.2 Japan Dementia Treatment Market
    • 8.2.1 Japan Dementia Treatment Market by Type
      • 8.2.1.1 Japan Dementia Treatment Market by Diagnosis Type
      • 8.2.1.2 Japan Dementia Treatment Market by Drug Class
    • 8.2.2 Japan Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.2.3 Japan Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.2.4 Japan Dementia Treatment Market by Indication
  • 8.3 India Dementia Treatment Market
    • 8.3.1 India Dementia Treatment Market by Type
      • 8.3.1.1 India Dementia Treatment Market by Diagnosis Type
      • 8.3.1.2 India Dementia Treatment Market by Drug Class
    • 8.3.2 India Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.3.3 India Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.3.4 India Dementia Treatment Market by Indication
  • 8.4 South Korea Dementia Treatment Market
    • 8.4.1 South Korea Dementia Treatment Market by Type
      • 8.4.1.1 South Korea Dementia Treatment Market by Diagnosis Type
      • 8.4.1.2 South Korea Dementia Treatment Market by Drug Class
    • 8.4.2 South Korea Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.4.3 South Korea Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.4.4 South Korea Dementia Treatment Market by Indication
  • 8.5 Singapore Dementia Treatment Market
    • 8.5.1 Singapore Dementia Treatment Market by Type
      • 8.5.1.1 Singapore Dementia Treatment Market by Diagnosis Type
      • 8.5.1.2 Singapore Dementia Treatment Market by Drug Class
    • 8.5.2 Singapore Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.5.3 Singapore Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.5.4 Singapore Dementia Treatment Market by Indication
  • 8.6 Malaysia Dementia Treatment Market
    • 8.6.1 Malaysia Dementia Treatment Market by Type
    • 8.6.2 Malaysia Dementia Treatment Market by Diagnosis Type
      • 8.6.2.1 Malaysia Dementia Treatment Market by Drug Class
      • 8.6.2.2 Malaysia Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.6.3 Malaysia Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.6.4 Malaysia Dementia Treatment Market by Indication
  • 8.7 Rest of Asia Pacific Dementia Treatment Market
    • 8.7.1 Rest of Asia Pacific Dementia Treatment Market by Type
      • 8.7.1.1 Rest of Asia Pacific Dementia Treatment Market by Diagnosis Type
      • 8.7.1.2 Rest of Asia Pacific Dementia Treatment Market by Drug Class
    • 8.7.2 Rest of Asia Pacific Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.7.3 Rest of Asia Pacific Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.7.4 Rest of Asia Pacific Dementia Treatment Market by Indication

Chapter 9. Company Profiles

  • 9.1 Eisai Co., Ltd.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expenses
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Trails and Approval:
    • 9.1.6 SWOT Analysis
  • 9.2 Eli Lilly And Company
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Regional Analysis
    • 9.2.4 Research & Development Expenses
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Acquisition and Mergers:
    • 9.2.6 SWOT Analysis
  • 9.3 F. Hoffmann-La Roche Ltd.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Partnerships, Collaborations, and Agreements:
    • 9.3.6 SWOT Analysis
  • 9.4 Biogen, Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 SWOT Analysis
  • 9.5 AbbVie, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 SWOT Analysis
  • 9.6 Novartis AG
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segmental and Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 SWOT Analysis
  • 9.7 Sun Pharmaceutical Industries Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 SWOT Analysis
  • 9.8 Takeda Pharmaceutical Company Limited
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Regional Analysis
    • 9.8.4 Research & Development Expense
    • 9.8.5 SWOT Analysis
  • 9.9 GlaxoSmithKline PLC (GSK)
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 SWOT Analysis
  • 9.10. Cipla Limited
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Segmental and Regional Analysis
    • 9.10.4 Research & Development Expense
    • 9.10.5 SWOT Analysis

LIST OF TABLES

  • TABLE 1 Asia Pacific Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 2 Asia Pacific Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 3 Asia Pacific Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 4 Asia Pacific Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 5 Asia Pacific Diagnosis Market by Country, 2020 - 2023, USD Million
  • TABLE 6 Asia Pacific Diagnosis Market by Country, 2024 - 2031, USD Million
  • TABLE 7 Asia Pacific Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 8 Asia Pacific Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 9 Asia Pacific Imaging Techniques Market by Country, 2020 - 2023, USD Million
  • TABLE 10 Asia Pacific Imaging Techniques Market by Country, 2024 - 2031, USD Million
  • TABLE 11 Asia Pacific Cognitive Assessment Tools Market by Country, 2020 - 2023, USD Million
  • TABLE 12 Asia Pacific Cognitive Assessment Tools Market by Country, 2024 - 2031, USD Million
  • TABLE 13 Asia Pacific Genetic Testing Market by Country, 2020 - 2023, USD Million
  • TABLE 14 Asia Pacific Genetic Testing Market by Country, 2024 - 2031, USD Million
  • TABLE 15 Asia Pacific Biomarker Analysis Market by Country, 2020 - 2023, USD Million
  • TABLE 16 Asia Pacific Biomarker Analysis Market by Country, 2024 - 2031, USD Million
  • TABLE 17 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
  • TABLE 18 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
  • TABLE 19 Asia Pacific Drugs Market by Country, 2020 - 2023, USD Million
  • TABLE 20 Asia Pacific Drugs Market by Country, 2024 - 2031, USD Million
  • TABLE 21 Asia Pacific Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 22 Asia Pacific Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 23 Asia Pacific Cholinesterase Inhibitors Market by Country, 2020 - 2023, USD Million
  • TABLE 24 Asia Pacific Cholinesterase Inhibitors Market by Country, 2024 - 2031, USD Million
  • TABLE 25 Asia Pacific NMDA Receptor Antagonist Market by Country, 2020 - 2023, USD Million
  • TABLE 26 Asia Pacific NMDA Receptor Antagonist Market by Country, 2024 - 2031, USD Million
  • TABLE 27 Asia Pacific MAO Inhibitors Market by Country, 2020 - 2023, USD Million
  • TABLE 28 Asia Pacific MAO Inhibitors Market by Country, 2024 - 2031, USD Million
  • TABLE 29 Asia Pacific Combination Drug Market by Country, 2020 - 2023, USD Million
  • TABLE 30 Asia Pacific Combination Drug Market by Country, 2024 - 2031, USD Million
  • TABLE 31 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
  • TABLE 32 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
  • TABLE 33 Asia Pacific Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 34 Asia Pacific Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 35 Asia Pacific Oral Market by Country, 2020 - 2023, USD Million
  • TABLE 36 Asia Pacific Oral Market by Country, 2024 - 2031, USD Million
  • TABLE 37 Asia Pacific Transdermal Patch Market by Country, 2020 - 2023, USD Million
  • TABLE 38 Asia Pacific Transdermal Patch Market by Country, 2024 - 2031, USD Million
  • TABLE 39 Asia Pacific Injectable Market by Country, 2020 - 2023, USD Million
  • TABLE 40 Asia Pacific Injectable Market by Country, 2024 - 2031, USD Million
  • TABLE 41 Asia Pacific Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 42 Asia Pacific Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 43 Asia Pacific Hospital Pharmacy Market by Country, 2020 - 2023, USD Million
  • TABLE 44 Asia Pacific Hospital Pharmacy Market by Country, 2024 - 2031, USD Million
  • TABLE 45 Asia Pacific Retail Pharmacy Market by Country, 2020 - 2023, USD Million
  • TABLE 46 Asia Pacific Retail Pharmacy Market by Country, 2024 - 2031, USD Million
  • TABLE 47 Asia Pacific Online Pharmacy Market by Country, 2020 - 2023, USD Million
  • TABLE 48 Asia Pacific Online Pharmacy Market by Country, 2024 - 2031, USD Million
  • TABLE 49 Asia Pacific Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 50 Asia Pacific Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 51 Asia Pacific Alzheimer's Disease Dementia Market by Country, 2020 - 2023, USD Million
  • TABLE 52 Asia Pacific Alzheimer's Disease Dementia Market by Country, 2024 - 2031, USD Million
  • TABLE 53 Asia Pacific Vascular Dementia Market by Country, 2020 - 2023, USD Million
  • TABLE 54 Asia Pacific Vascular Dementia Market by Country, 2024 - 2031, USD Million
  • TABLE 55 Asia Pacific Lewy Body Dementia Market by Country, 2020 - 2023, USD Million
  • TABLE 56 Asia Pacific Lewy Body Dementia Market by Country, 2024 - 2031, USD Million
  • TABLE 57 Asia Pacific Frontotemporal Dementia (FTD) Market by Country, 2020 - 2023, USD Million
  • TABLE 58 Asia Pacific Frontotemporal Dementia (FTD) Market by Country, 2024 - 2031, USD Million
  • TABLE 59 Asia Pacific Parkinson Disease Dementia Market by Country, 2020 - 2023, USD Million
  • TABLE 60 Asia Pacific Parkinson Disease Dementia Market by Country, 2024 - 2031, USD Million
  • TABLE 61 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
  • TABLE 62 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
  • TABLE 63 Asia Pacific Dementia Treatment Market by Country, 2020 - 2023, USD Million
  • TABLE 64 Asia Pacific Dementia Treatment Market by Country, 2024 - 2031, USD Million
  • TABLE 65 China Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 66 China Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 67 China Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 68 China Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 69 China Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 70 China Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 71 China Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 72 China Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 73 China Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 74 China Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 75 China Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 76 China Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 77 China Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 78 China Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 79 Japan Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 80 Japan Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 81 Japan Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 82 Japan Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 83 Japan Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 84 Japan Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 85 Japan Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 86 Japan Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 87 Japan Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 88 Japan Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 89 Japan Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 90 Japan Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 91 Japan Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 92 Japan Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 93 India Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 94 India Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 95 India Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 96 India Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 97 India Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 98 India Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 99 India Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 100 India Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 101 India Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 102 India Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 103 India Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 104 India Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 105 India Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 106 India Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 107 South Korea Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 108 South Korea Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 109 South Korea Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 110 South Korea Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 111 South Korea Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 112 South Korea Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 113 South Korea Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 114 South Korea Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 115 South Korea Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 116 South Korea Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 117 South Korea Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 118 South Korea Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 119 South Korea Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 120 South Korea Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 121 Singapore Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 122 Singapore Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 123 Singapore Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 124 Singapore Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 125 Singapore Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 126 Singapore Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 127 Singapore Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 128 Singapore Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 129 Singapore Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 130 Singapore Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 131 Singapore Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 132 Singapore Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 133 Singapore Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 134 Singapore Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 135 Malaysia Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 136 Malaysia Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 137 Malaysia Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 138 Malaysia Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 139 Malaysia Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 140 Malaysia Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 141 Malaysia Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 142 Malaysia Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 143 Malaysia Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 144 Malaysia Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 145 Malaysia Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 146 Malaysia Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 147 Malaysia Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 148 Malaysia Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 149 Rest of Asia Pacific Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 150 Rest of Asia Pacific Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 151 Rest of Asia Pacific Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 152 Rest of Asia Pacific Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 153 Rest of Asia Pacific Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 154 Rest of Asia Pacific Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 155 Rest of Asia Pacific Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 156 Rest of Asia Pacific Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 157 Rest of Asia Pacific Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 158 Rest of Asia Pacific Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 159 Rest of Asia Pacific Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 160 Rest of Asia Pacific Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 161 Rest of Asia Pacific Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 162 Rest of Asia Pacific Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 163 Key Information - Eisai Co., Ltd.
  • TABLE 164 Key Information - Eli Lilly And Company
  • TABLE 165 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 166 Key Information - Biogen, Inc.
  • TABLE 167 Key information - AbbVie, Inc.
  • TABLE 168 Key Information - Novartis AG
  • TABLE 169 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 170 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 171 Key Information - GlaxoSmithKline PLC
  • TABLE 172 Key Information - Cipla Limited
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!